当前位置： SCI文献检索 > CHEMICO-BIOLOGICAL INTERACTIONS期刊下所有文献 > Simvastatin down-regulates differential genetic profiles produced by organochlorine mixtures in primary breast cell (HMEC).

Simvastatin down-regulates differential genetic profiles produced by organochlorine mixtures in primary breast cell (HMEC).

Abstract：

:Women all over the world are exposed to an unavoidable contamination by organochlorine pesticides and other chemical pollutants. Many of them are considered as xenoestrogens and have been associated with the development and progression of breast cancer. We have demonstrated that the most prevalent pesticide mixtures found in healthy women and in women diagnosed with breast cancer modulates the gene expression in human epithelial mammary cells. Statins are well-known cholesterol-depleting agents acting as inhibitors of cholesterol synthesis. Since the early 1990s, it has been known that statins could be successfully used in cancer therapy, including breast cancer, but the exact mechanism behind anti-tumor activity of the statins remains unclear. In the present study we evaluated the effect of simvastatin in the gene expression pattern induced by realistic organochlorine mixtures found in breast cancer patients. The gene expression of 94 genes related with the cell signaling pathways were assessed. Our results indicate that simvastatin exerts a global down regulating effect on successfully determined genes (78.7%), thus attenuating the effects induced by organochlorine mixtures on the gene profile of human mammary epithelial cells. This effect was more evident on genes whose function is the ATP-binding process (that also were particularly up-regulated by pesticide mixtures). We also found that MERTK (a proto-oncogene which is overexpressed in several malignancies) and PDGFRB (a member of the platelet-derived growth factor family whose expression is high in breast-cancer cells that have become resistant to endocrine therapy) were among the genes with a higher differential regulation by simvastatin. Since resistance to treatment with tyrosine kinase inhibitors is closely related to MERKT, our findings would enhance the possible utility of statins in breast cancer treatment, i.e. improving therapeutic results combining statins with tyrosine Kinase inhibitors.

journal_name

Chem Biol Interact

journal_title

Chemico-biological interactions

authors

Rivero J,Henríquez-Hernández LA,D Boada L,Pestano J,P Luzardo O,Camacho M,Zumbado M,F Valerón P

doi

10.1016/j.cbi.2017.03.001

subject

Has Abstract

pub_date

2017-04-25 00:00:00

pages

85-92

eissn

0009-2797

issn

1872-7786

pii

S0009-2797(16)30588-9

journal_volume

268

pub_type

信件

在线工具

Simvastatin down-regulates differential genetic profiles produced by organochlorine mixtures in primary breast cell (HMEC).